Bio Solution Co.,Ltd. (KOSDAQ:086820)
11,100
-550 (-4.72%)
At close: Apr 9, 2026
Bio Solution Market Cap
Bio Solution has a market cap or net worth of 272.67 billion as of April 10, 2026. Its market cap has increased by 36.41% in one year.
Market Cap
272.67B
Enterprise Value
291.48B
Revenue
15.20B
Ranking
n/a
PE Ratio
997.46
Stock Price
11,100.00
Market Cap Chart
Since August 20, 2018, Bio Solution's market cap has increased from 218.31B to 272.67B, an increase of 24.90%. That is a compound annual growth rate of 2.95%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 268.31B | 40.33% |
| Dec 30, 2025 | 191.20B | 10.84% |
| Dec 30, 2024 | 172.51B | 10.88% |
| Dec 28, 2023 | 155.58B | 82.92% |
| Dec 29, 2022 | 85.05B | -50.94% |
| Dec 30, 2021 | 173.35B | -26.16% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Aug 20, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Y-Biologics | 365.03B |
| S.Biomedics | 317.06B |
| TiumBio | 315.79B |
| NIBEC | 291.54B |
| curacle co.,ltd. | 283.77B |
| Genome & Company | 236.57B |
| Kangstem Biotech | 215.89B |
| ABION | 197.77B |